A multi-center retrospective study comparing one-step nucleic amplification and conventional ultrastaging for sentinel lymph node assessment in early-stage endometrial cancer.

Saved in:
Bibliographic Details
Title: A multi-center retrospective study comparing one-step nucleic amplification and conventional ultrastaging for sentinel lymph node assessment in early-stage endometrial cancer.
Authors: Vallés E; Hospital Universitari Vall d'Hebron, Gynecologic Oncology Division, Vall d'Hebron Hospital Campus, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain; Hospital Clínic de Barcelona, Institute Clinic of Gynecology, Obstetrics and Neonatology, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain; Institut de Recerca Vall d'Hebron (VHIR), CIBERONC, Barcelona, Spain., Bebia V; Hospital Universitari Vall d'Hebron, Gynecologic Oncology Division, Vall d'Hebron Hospital Campus, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain; Institut de Recerca Vall d'Hebron (VHIR), CIBERONC, Barcelona, Spain., García-Pineda V; Hospital Universitario La Paz, Gynecologic Oncology Unit, Madrid, Spain., Gracia M; Hospital Universitario La Paz, Gynecologic Oncology Unit, Madrid, Spain., Hardisson D; Hospital Universitario La Paz, Department of Pathology, Instituto de Salud Carlos III, CIBERONC, Molecular Pathology and Therapeutic Targets Group, IdiPAZ, Universidad Autónoma de Madrid, Faculty of Medicine, Madrid, Spain., Díaz-Feijoo B; Hospital Clínic de Barcelona, Institute Clinic of Gynecology, Obstetrics and Neonatology, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain., Carreras N; Hospital Clínic de Barcelona, Institute Clinic of Gynecology, Obstetrics and Neonatology, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain., Fernández-González S; Hospital Universitari de Bellvitge, Department of Gynecology, IDIBELL, Universitat de Barcelona (UB), Barcelona, Spain., Padilla-Iserte P; Hospital Universitario y Politécnico La Fe, Gynecologic Oncology Unit, Health Research Institute La Fe (IIS La Fe), Valencia, Spain., Carballas E; Hospital Universitari Germans Trias i Pujol, Gynecologic Oncology Unit, Badalona, Spain., López de la Manzanara C; Hospital General Universitario de Ciudad Real, Department of Obstetrics and Gynecology, Ciudad Real, Spain., Oliver-Pérez R; Hospital Universitario 12 de Octubre, Gynecologic Oncology Unit, Department of Obstetrics and Gynecology, Instituto de Investigación i+12, Complutense University of Madrid, Madrid, Spain., Sanchis J; Instituto Valenciano de Oncología (IVO), Gynecologic Oncology Unit, Valencia, Spain., Pantoja M; Hospital Universitario Virgen Macarena, Department of Obstetrics and Gynecology, Sevilla, Spain., Mancebo G; Hospital del Mar, Gynecologic Oncology Unit, Barcelona, Spain., Agababyan C; Hospital General Universitario de Valencia, Department of Obstetrics and Gynecology, Valencia, Spain., Escayola C; Hospital El Pilar Quirónsalud, Department of Obstetrics and Gynecology, Barcelona, Spain., Torrent A; Hospital Universitari Son Espases, Department of Obstetrics and Gynecology, Palma de Mallorca, Spain., Gómez Del Valle M; Hospital General de Catalunya, Department of Obstetrics, Gynecology and Reproductive Medicine Dexeus Mujer, Sant Cugat del Vallès, Spain., Fidalgo S; Hospital Universitario Central de Asturias, Department of Obstetrics and Gynecology, Oviedo, Spain., Gómez T; Hospital Virgen de la Victoria, Department of Obstetrics and Gynecology, Málaga, Spain., Roldán F; Hospital Clínico Universitario de Zaragoza, Department of Obstetrics and Gynecology, Zaragoza, Spain., Alonso P; Hospital Universitario Gregorio Marañón, Department of Obstetrics and Gynecology, Madrid, Spain., Quesada A; Hospital Universitario Nuestra Señora de Candelaria, Department of Obstetrics and Gynecology, Tenerife, Spain., Chacón E; Clínica Universidad de Navarra, Cancer Center (CCUN), Department of Obstetrics and Gynecology, Pamplona, Spain., Muruzabal JC; Hospital Universitario de Navarra, Department of Obstetrics and Gynecology, Pamplona, Spain., García-Cano DG; Complejo Hospitalario Universitario Insular Materno Infantil, Department of Obstetrics and Gynecology, Gran Canaria, Spain., Calvo A; Hospital Universitari Arnau de Vilanova, Department of Obstetrics and Gynecology, Lleida, Spain., Gil-Moreno A; Hospital Universitari Vall d'Hebron, Gynecologic Oncology Division, Vall d'Hebron Hospital Campus, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain; Institut de Recerca Vall d'Hebron (VHIR), CIBERONC, Barcelona, Spain., Cabrera S; Hospital de la Santa Creu i Sant Pau, Gynecologic Oncology Unit, IR Sant Pau, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain. Electronic address: scabrera@santpau.cat.
Corporate Authors: Spain-GOG and the MULTISENT Study Group
Source: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2026 Jun; Vol. 36 (6), pp. 104678. Date of Electronic Publication: 2026 Apr 03.
Publication Type: Journal Article; Multicenter Study; Comparative Study
Journal Info: Publisher: BMJ Country of Publication: United States NLM ID: 9111626 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-1438 (Electronic) Linking ISSN: 1048891X NLM ISO Abbreviation: Int J Gynecol Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1525-1438
DOI:10.1016/j.ijgc.2026.104678